151 related articles for article (PubMed ID: 10845878)
21. [Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction].
Huang X; Zhu M; Jin X; Zhang D; Wang L; Ye Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):653-6. PubMed ID: 19065524
[TBL] [Abstract][Full Text] [Related]
22. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A
J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578
[TBL] [Abstract][Full Text] [Related]
23. MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion.
Maqbool A; Keswani A; Galloway S; O'Regan DJ; Ball SG; Turner NA; Porter KE
J Surg Res; 2012 Jun; 175(2):343-9. PubMed ID: 21601886
[TBL] [Abstract][Full Text] [Related]
24. Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese.
Huang XY; Han LY; Huang XD; Guan CH; Mao XL; Ye ZS
Int J Neurosci; 2016 Oct; 126(10):936-41. PubMed ID: 26314579
[TBL] [Abstract][Full Text] [Related]
25. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.
Beyzade S; Zhang S; Wong YK; Day IN; Eriksson P; Ye S
J Am Coll Cardiol; 2003 Jun; 41(12):2130-7. PubMed ID: 12821236
[TBL] [Abstract][Full Text] [Related]
26. The 5A Allele of the MMP3-Gene Promoter Polymorphism Is a Risk Factor for Poor Outcome of Hemodialysis Patients.
Dragovic JT; Popovic J; Djuric P; Bulatovic A; Jankovic A; Buzadzic I; Dimkovic N
Tohoku J Exp Med; 2017 Aug; 242(4):273-279. PubMed ID: 28781337
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
Sherva R; Ford CE; Eckfeldt JH; Davis BR; Boerwinkle E; Arnett DK
Stroke; 2011 Feb; 42(2):330-5. PubMed ID: 21183746
[TBL] [Abstract][Full Text] [Related]
28. [Association of MMP3 promoter 5A/6A polymorphism with stability of extracellular matrix of atherosclerotic plaque].
Du J; Liu Y; Gao J; Chen S; Jiang H; Zhao L; Cong H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jun; 36(6):645-648. PubMed ID: 31055827
[TBL] [Abstract][Full Text] [Related]
29. Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus.
Marasini B; Massarotti M; De Monti M; Erario M; Ghilardi G; Biondi ML
J Clin Immunol; 2008 Mar; 28(2):131-3. PubMed ID: 17975717
[TBL] [Abstract][Full Text] [Related]
30. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis.
Djurić T; Zivković M; Radak D; Jekić D; Radak S; Stojković L; Raicević R; Stanković A; Alavantić D
Clin Biochem; 2008 Nov; 41(16-17):1326-9. PubMed ID: 18801353
[TBL] [Abstract][Full Text] [Related]
31. The association of the metalloproteinase-3 gene promoter polymorphisms and the middle cerebral artery stenosis.
Fu C; Xing Y; Song X
Cell Biochem Biophys; 2011 Apr; 59(3):185-9. PubMed ID: 21113741
[TBL] [Abstract][Full Text] [Related]
32. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
Samnegård A; Silveira A; Lundman P; Boquist S; Odeberg J; Hulthe J; McPheat W; Tornvall P; Bergstrand L; Ericsson CG; Hamsten A; Eriksson P
J Intern Med; 2005 Nov; 258(5):411-9. PubMed ID: 16238676
[TBL] [Abstract][Full Text] [Related]
33. [Matrix metalloproteinase-3 genotype distribution and its relation with blood pressure profiles in Guangzhou rural population].
Shao Y; Deng M; Lian Z; Shi M; Jiang X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):586-9. PubMed ID: 23644126
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
[TBL] [Abstract][Full Text] [Related]
35. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene.
Takahashi M; Haro H; Wakabayashi Y; Kawa-uchi T; Komori H; Shinomiya K
J Bone Joint Surg Br; 2001 May; 83(4):491-5. PubMed ID: 11380116
[TBL] [Abstract][Full Text] [Related]
36. MMP3 -1171 5A/6A Promoter Genotype Influences Serum MMP3 Levels and Is Associated with Deep Venous Thrombosis.
Li XP; Wan GZ; Wang GJ; Li JF
Ann Vasc Surg; 2016 Jul; 34():261-7. PubMed ID: 27177702
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
38. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease].
Gao B; Li ZC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616
[TBL] [Abstract][Full Text] [Related]
39. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis.
Ye S; Humphries S; Henney A
Clin Sci (Lond); 1998 Feb; 94(2):103-10. PubMed ID: 9536917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
